Identification of patients with high-risk stage II colon cancer for adjuvant therapy Academic Article uri icon

Overview

MeSH Major

  • Adenocarcinoma
  • Colonic Neoplasms

abstract

  • Patients with Stage II colon cancer generally have an excellent prognosis. However, the presence of multiple adverse prognostic factors identifies a high-risk subgroup. Use of commonly reported clinicopathologic features accurately stratifies Stage II colon cancer by disease-specific survival. Those identified as high-risk patients can be considered for adjuvant chemotherapy and/or enrollment in investigational trials.

publication date

  • May 2008

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1007/s10350-008-9246-z

PubMed ID

  • 18322753

Additional Document Info

start page

  • 503

end page

  • 7

volume

  • 51

number

  • 5